OKUR OnKure Therapeutics, Inc. logo

OKUR OnKure Therapeutics, Inc.

Healthcare
$4.12-2.14%ClosedMarket Cap: $56.3M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

4

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+660,000

Shares Acquired

660,000

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Apr 07AI Biotechnology LLC10 percent ownerSell5,640,222$0.000
Tue Apr 07AI Biotechnology LLC10 percent ownerSell0$0.003,998,332
Fri Apr 03Saccomano Nicholas Adirector, officer: President and CEOSell330,000$4.07330,000
Fri Apr 03Leverone Jason A.officer: Chief Financial OfficerSell110,000$4.07110,000
Fri Apr 03Hartley Dylanofficer: Chief Scientific OfficerSell110,000$4.07110,000
Fri Apr 03Agresta Samuelofficer: Chief Medical OfficerSell110,000$4.07110,000
Wed Apr 01Ratcliffe LiamdirectorSell15,300$4.1415,300
Wed Apr 01Ratcliffe LiamSell0$0.000
Tue Mar 24Saccomano Nicholas Adirector, officer: President and CEOSell86$4.167,333
Tue Mar 24Leverone Jason A.officer: Chief Financial OfficerSell301$4.1616,000
Fri Jan 02Mathers Edward TdirectorSell3,911$0.0015,310
Fri Jan 02Manke IsaacdirectorSell5,258$0.0020,583
Tue Dec 23Saccomano Nicholas Adirector, officer: President and CEOSell87$2.977,419
Tue Dec 23Leverone Jason A.officer: Chief Financial OfficerSell302$2.9716,301
Thu Oct 02Mathers Edward TdirectorSell4,125$0.0011,399